Revenue seems to be slipping in the acute sector but they are doing well in non-acute. Seems the 500k research grant is no more so that's also impacted 'revenue'.
Higher salaries and expenses probably due to the SA dispute.
Now that they are cashed up hopefully they can further develop their products.
Ann: Dividend/Distribution - GLH, page-4
Add GLH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $7.836M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $6.465K | 48.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39384 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 1585 | 1 |
View Market Depth
| Last trade - 15.35pm 29/11/2024 (20 minute delay) ? |
| GLH (ASX) Chart |
